Increasing the Use of SaaS Signifies a Shift in Healthcare Clinical Trial Management Systems Market Unveils Fact.MR

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Click Here to Get Complete Synopsis of this Report

https://www.factmr.com/report/832/clinical-trial-management-systems-market

Highlights

Clinical trial management systems market to surpass US$ 1 Bn during the review period

Incremental opportunity of US$ 116 Mn in web-based clinical trial management systems market

U.S. and EU5 among the most lucrative markets globally for vendors
Web-based clinical trial management systems continue to be the preferred mode of deployment for pharmaceutical and biotechnology companies, finds a new study by Fact.MR. The report projects that web-based clinical trial management systems will remain pervasive in the clinical trial management systems market during the review period 2018-2028, gaining an impressive US$ 116 Mn in incremental opportunity in a decade.

For detailed insights on enhancing your product footprint, request a sample here –
https://www.factmr.com/connectus/sample?flag=S&rep_id=832

Company Profiles

Medidata Solutions
PAREXEL International Inc.
International Business Machines Corporation (IBM)
Bioclinica
Oracle Corporation
Cognizant Technology Solutions Corporation
DSG, Inc.
Forte Research Systems, Inc.
Veeva Systems
Bio-Optronics, Inc.

For critical insights on this market, request for methodology here –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=832

Clinical Trial Management Systems Market to Surpass US$ 1 Billion During the Course of Forecast Period

The report is bullish on the prospects of clinical trial management systems market, and expects revenues to surpass US$ 1 billion during the course of the forecast period. Growth will be induced by a range of macroeconomic and industry-specific factors, with growing awareness on the critical role of clinical trial management systems in improving workflow influencing investment.

Clinical Trial Management Systems Market: Sensitization on Benefits over Paper-based Driving Growth

The report finds that sensitization about the operational benefits of clinical trial management system over manual paper-based process has been a key factor for increased adoption. While a majority of end-users are using clinical trial management systems in-house, a significant percentage of end-users also outsource to vendors, such as CROs and SMOs. Outsourcing of site monitoring, site management, and schedule tracking functions was highest among end-users.

For More Insights:

https://www.biospace.com/article/dual-chamber-prefilled-syringes-market-surging-at-8-7-percent-cagr-driven-by-robust-proliferated-penetration-of-lyophilized-drugs-fact-mr/

According to the report, standardization, SaaS-based solutions, and flexibility in terms of pricing and licensing are among the key evolutions in the clinical trial management system market. The increasing complexity in clinical trials has meant that pharmaceutical companies prefer outsourcing clinical trial execution to contract organizations. Outsourcing is likely to gain further momentum during the assessment period as proliferation of specialty clinical research organizations and academic research organizations (AROs) witnesses a spike.

The report finds that revenues generated from clinical trial management software are higher than services, and the status quo is unlikely to remain unchanged during the assessment period. The revenues generated from clinical trial management software is nearly 3x of services in 2018, and both these segments are likely to grow at similar CAGR during the assessment period.

Preference for enterprise-based clinical trial management systems is higher among end-users. The preference for enterprise-based clinical trial management systems can be gauged by the fact that this segment accounted for nearly three-fourth revenue share of the market in 2018. The preference for enterprise-based clinical trials is likely to continue unabated during the review period.

For in-depth competitive analysis, buy now –

https://www.factmr.com/checkout/832

Adoption of clinical trial management systems is mainly concentrated among pharmaceutical companies, contract research organizations (CROs), and healthcare providers. Pharmaceutical companies account for nearly three-fourth revenue share of the clinical trial management systems market, with healthcare providers accounting for a miniscule revenue share.

The penetration rate of clinical trial management systems is higher in the US and EU5, with pharmaceutical companies and other end-users adopting a proactive approach towards adoption of advanced software and services. The proliferation of clinical trial management systems in the US is reflected by the statistic that the country accounts for nearly 40% revenue share of the global clinical trial management systems market. The adoption rate is also impressive in Canada, albeit the market is likely to grow from a small base.

According to the report, adoption of clinical trial management systems in Europe is concentrated in Germany, U.K., Spain, Italy, and France. These five markets collectively account for nearly 68% revenue share of the clinical trial management systems market. Germany is likely to retain its position as the most lucrative market for clinical trial management systems, whereas growth is likely to be sluggish in the U.K.

Explore Fact.MR’s Comprehensive Coverage on ICT Landscape

Push-to-Talk (PTT) Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/push-to-talk-ptt-market

Contactless Biometrics Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/contactless-biometrics-market

Wearable Exoskeleton Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/3436/wearable-exoskeletons-market

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.